The FDA lists an ongoing Class II recall of dexmedetomidine hydrochloride in 0.9% sodium chloride, 400 mcg per 100 mL (4 mcg/mL), in single-dose 100 mL Galaxy containers from Baxter Healthcare. The stated reason is deviations from current good manufacturing practice.
Class II means use may cause temporary or medically reversible harm, or that serious harm is remote. The record does not describe a specific defect. The product is widely used for ICU and procedural sedation in the US; whether Indian supply is affected is not stated.
- Ask pharmacy whether your ICU or theatres stock the recalled premixed bags.
- Quarantine affected lots and use an alternative presentation.
- Check infusion pump libraries if switching concentration.
Why it matters
A concentration change during a supply switch is a common route to infusion errors.
Don't overread it
A manufacturing-practice recall, not a reported patient safety signal.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free